166 related articles for article (PubMed ID: 38473232)
1. The Correlation between Morpho-Dynamic Contrast-Enhanced Mammography (CEM) Features and Prognostic Factors in Breast Cancer: A Single-Center Retrospective Analysis.
Piccolo CL; Celli I; Bandini C; Tommasiello M; Sammarra M; Faggioni L; Cioni D; Beomonte Zobel B; Neri E
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473232
[TBL] [Abstract][Full Text] [Related]
2. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer.
Li N; Gong W; Xie Y; Sheng L
Breast; 2023 Dec; 72():103595. PubMed ID: 37925875
[TBL] [Abstract][Full Text] [Related]
4. Are contrast enhanced mammography and digital breast tomosynthesis equally effective in diagnosing patients recalled from breast cancer screening?
Siminiak N; Pasiuk-Czepczyńska A; Godlewska A; Wojtyś P; Olejnik M; Michalak J; Nowaczyk P; Gajdzis P; Godlewski D; Ruchała M; Czepczyński R
Front Oncol; 2022; 12():941312. PubMed ID: 36505843
[TBL] [Abstract][Full Text] [Related]
5. Multireader comparison of contrast-enhanced mammography versus the combination of digital mammography and digital breast tomosynthesis in the preoperative assessment of breast cancer.
Girometti R; Linda A; Conte P; Lorenzon M; De Serio I; Jerman K; Londero V; Zuiani C
Radiol Med; 2021 Nov; 126(11):1407-1414. PubMed ID: 34302599
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies.
Bellini C; Pugliese F; Bicchierai G; Amato F; De Benedetto D; Di Naro F; Boeri C; Vanzi E; Migliaro G; Incardona L; Tommasi C; Orzalesi L; Miele V; Nori J
Breast Cancer; 2024 May; ():. PubMed ID: 38811515
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced mammography in breast cancer screening.
Coffey K; Jochelson MS
Eur J Radiol; 2022 Nov; 156():110513. PubMed ID: 36108478
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
11. Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old).
Huang J; Lin Q; Cui C; Fei J; Su X; Li L; Ma J; Zhang M
Jpn J Radiol; 2020 Nov; 38(11):1062-1074. PubMed ID: 32562180
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
[TBL] [Abstract][Full Text] [Related]
13. Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging.
Marino MA; Leithner D; Sung J; Avendano D; Morris EA; Pinker K; Jochelson MS
Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32708512
[TBL] [Abstract][Full Text] [Related]
14. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
Gelardi F; Ragaini EM; Sollini M; Bernardi D; Chiti A
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010240
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
[TBL] [Abstract][Full Text] [Related]
18. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
[TBL] [Abstract][Full Text] [Related]
19. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
Coffey K; Dixon LB; Sevilimedu V; Jochelson MS; Sung JS
Eur J Radiol; 2023 Nov; 168():111097. PubMed ID: 37738835
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
